SCREENING FOR PREECLAMPSIA: A EVIDENCE-BASED REVIEW

Abstract

Pre-eclampsia is part of a spectrum of conditions known as the hypertensive disorders of pregnancy and is defined as hypertension and proteinuria detected for the first time in the second half of pregnancy, after 20 weeks’ gestation. Pre-eclampsia complicates 2–10% of pregnancies and is one of the important causes of maternal mortality and death perinatal, special focus on the developing country. However, the majority of deaths due to pre-eclampsia and eclampsia can be avoidable through the provision of timely and effective care to the women presenting with these complications, especially in women with high risk factors of pre-eclampsia. Optimizing to manage this disoders are screening and preventing women who is in high risk to develop preeclampsia. WHO and obstetrics and gynecology associations have developed and updated the recommendations for prevention and treatment of pre-eclampsia. This review base on the WHO and obstetrics associations recommendations as well as a series studies were performed and published in Viet Nam from 2014 to 2016. The review contributes to provid evidence-based recommendations for clinical practice and management of hypertensive disorders in pregnancy, this is a necessary step towards achieving the Millennium Development Goals. Key words: preeclampsia, hypertension disorder, screening, high risk pregnancy, evidence-based